MySequenom
•
Contact
•
Search for:
Prenatal
Ophthalmology
Leadership Team
Board of Directors
Clinical Advisory Boards
Locations and Contact
How it Works
QGE Performance
Data Normalization
ADME PGx Genotyping
SNP Genotyping
DNA Methylation
Molecular Typing
Somatic Mutation Profiling
Gene Expression Analysis
Translational Research
Cancer Solutions
Agricultural Genomics
Wish List
Request Information
Applications
Research Areas
Assay Explorer
System
General Purpose Reagents
Fetal Nucleic Acid Technology
Clinical Studies
Prenatal
Retinal Care
Genetic Analysis
Diagnostics Pipeline
Literature
Archive
News
Newsletters
Events
Financial Reports
Fundamentals
Stock Information
Events and Webcasts
SEC Filings
Corporate Governance
Analyst Coverage
Email Alerts
Open Positions
Benefits
Development
Diversity
Activities & Services
Recruiter Message
About Us
Products & Services
Newsroom
Investor Relations
Careers
Support
In the News
2011 Analyst and Investor Day Presentation
Analyst Day Webcast
2/2/2012
- Study Published In Genetics In Medicine Demonstrates Sequenom CMM MaterniT21 Test Accurately Detects Two Additional Fetal Trisomies
1/25/2012
- Sequenom Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of Common Stock
Spotlight
Sequenom CMM Introduces MaterniT21 Noninvasive Prenatal Test for Down Syndrome
Assay Explorer
is a tool for finding pre-designed assays for genotyping and somatic mutation experiments using Sequenom's MassARRAY system
Featured Publications
Using MassARRAY in a Laboratory Developed Test Using Cystic Fibrosis Carrier Screening as a Model
Prostate cancer suscepibility loci identified on chromosome 12 in African Americans
GWAS-identified colorectal cancer susceptibility locus associates with disease prognosis